Prospective evaluation of serum alkaline phosphatase variability and prognostic utility in primary sclerosing cholangitis using controlled clinical trial data

被引：2

作者：

Trivedi, Palak ^{[1
,2
,3
,4
,5
]}

Muir, Andrew ^{[6
]}

Levy, Cynthia ^{[7
]}

Bowlus, Christopher ^{[8
]}

Manns, Michael P. ^{[9
]}

Lu, Xiaomin ^{[10
]}

Crans, Gerald ^{[10
]}

Subramanian, Mani ^{[10
]}

Myers, Robert ^{[10
]}

Goodman, Zachary ^{[11
]}

Chalasani, Naga ^{[12
]}

Vierling, John M. ^{[13
]}

Guha, Neil ^{[14
]}

Hirschfield, Gideon ^{[15
]}

机构：

[1] NIHR Birmingham BRC, Birmingham, W Midlands, England

[2] Ctr Liver Res, Birmingham, W Midlands, England

[3] Inst Immunol & Immunotherapy, Birmingham, W Midlands, England

[4] Inst Appl Hlth Res, Birmingham, W Midlands, England

[5] Univ Hosp Birmingham Queen Elizabeth, Liver Unit, Birmingham, W Midlands, England

[6] Duke Clin Res Inst, Durham, NC USA

[7] Univ Miami, Miami, FL USA

[8] Univ Calif Davis, Davis, CA 95616 USA

[9] Hannover Med Sch, Hannover, Germany

[10] Gilead Sci Inc, 353 Lakeside Dr, Foster City, CA 94404 USA

[11] Inova Fairfax Hosp, Annandale, VA USA

[12] Indiana Univ Sch Med, Indianapolis, IN 46202 USA

[13] Baylor Coll Med, Houston, TX 77030 USA

[14] Univ Nottingham, NIHR Nottingham BRC, Nottingham, England

[15] Univ Toronto, Toronto Ctr Liver Dis, Univ Hlth Network, Toronto, ON, Canada

来源：

JOURNAL OF HEPATOLOGY | 2019年 / 70卷 / 01期

关键词：

D O I：

10.1016/S0618-8278(19)30022-2

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

PS-016

引用

页码：E12 / E13

页数：2

共 50 条

[31] Serum gamma-glutamyltransferase is a prognostic biomarker in primary biliary cholangitis and improves risk stratification based on alkaline phosphatase
Gerussi, A.
Bernasconi, D.
O'donnell, S. E.
Lammers, W. J.
Van Buuren, H.
Hirschfield, G.
Janssen, H.
Corpechot, C.
Reig, A.
Pares, A.
Battezzati, P. M.
Zuin, M. G.
Cazzagon, N.
Floreani, A.
Nevens, F.
Gatselis, N.
Dalekos, G.
Mayo, M. J.
Thorburn, D.
Bruns, T.
Mason, A. L.
Xavier, V.
Kowdley, K.
Invernizzi, P.
Hansen, B.
Carbone, M.
DIGESTIVE AND LIVER DISEASE, 2020, 52 : E4 - E5
[32] Serum gamma-glutamyltransferase is a prognostic biomarker in primary biliary cholangitis and improves risk stratification based on the alkaline phosphatase
Gerussi, Alessio
Bernasconi, Davide
O'Donnell, Sarah Elisabeth
Lammers, Willem J.
Van Buuren, Henk
Hirschfield, Gideon
Janssen, Harry
Corpechot, Christophe
Reig, Anna
Pares, Albert
Battezzati, Pier Maria
Zuin, Massimo Giovanni
Cazzagon, Nora
Floreani, Annarosa
Nevens, Frederik
Gatselis, Nikolaos
Dalekos, George
Mayo, Marlyn J.
Thorburn, Douglas
Bruns, Tony
Mason, Andrew L.
Xavier, Verhelst
Kowdley, Kris
Invernizzi, Pietro
Hansen, Bettina
Carbone, Marco
JOURNAL OF HEPATOLOGY, 2020, 73 : S459 - S460
[33] Prospective evaluation of serum gamma-glutamyl transferase (GGT) for the prediction of disease progression in a randomized trial of patients with primary sclerosing cholangitis (PSC)
Levy, C.
Shiffman, M.
Janssen, H.
Montano-Loza, A.
Caldwell, S.
Luketic, V.
Ding, D.
Mccolgan, B.
Myers, R.
Eksteen, B.
Chapman, R. W. G.
Manns, M. P.
Goodman, Z.
Bowlus, C.
Muir, A.
Hirschfield, G.
JOURNAL OF HEPATOLOGY, 2018, 68 : S568 - S568
[34] Improvement of serum alkaline phosphatase to <1.5 upper limit of normal predicts better outcome and reduced risk of cholangiocarcinoma in primary sclerosing cholangitis
Al Mamari, Said
Djordjevic, Jelena
Halliday, John S.
Chapman, Roger W.
JOURNAL OF HEPATOLOGY, 2013, 58 (02) : 329 - 334
[35] Radiologic progression in primary sclerosing cholangitis (PSC) by two-dimensional magnetic resonance cholangiopancreatography (MRCP): Prospective data from a randomized controlled trial
Muir, Andrew J.
Taghipour, Mehdi
Hassanzadeh, Elmira
Sahni, V. Anik
Sainani, Nisha
Shiffman, Mitchell L.
Ding, Dora
Jia, Catherine
McColgan, Bryan J.
Myers, Robert P.
Subramanian, Mani
McHutchison, John G.
Goodman, Zachary D.
Eksteen, Bertus
Manns, Michael P.
Levy, Cynthia
Bowlus, Christopher L.
Chapman, Roger W.
Tempany-Afdhal, Clare
HEPATOLOGY, 2017, 66 : 156A - 156A
[36] Improvement of Serum Alkaline Phosphatase to Less Than 1.5 the Upper Limit of Normal is Associated With a Better Prognosis in Patients With Primary Sclerosing Cholangitis (PSC)
Al Mamari, Said
Djordjevic, Jelena
Halliday, John S.
Chapman, Roger W.
GASTROENTEROLOGY, 2012, 142 (05) : S911 - S912
[37] A reduction in alkaline phosphatase levels is associated to improved prognosis in primary sclerosing cholangitis: A 14 year follow up of the Scandinavian ursodeoxycholic acid trial
Lindstrom, Lina
Boberg, Kirsten M.
Friis-Liby, Ingalill
Hultcrantz, Rolf W.
Bergquist, Annika
HEPATOLOGY, 2012, 56 : 247A - 247A
[38] Clinical Utility of Personalized Serum IgG Subclass Ratios for the Differentiation of IgG4-Related Sclerosing Cholangitis (IgG4-SC) from Primary Sclerosing Cholangitis (PSC) and Cholangiocarcinoma (CCA)
Park, Jae Keun
Kim, Dongwuk
Lee, Jeong Min
Lee, Kwang Hyuck
Lee, Kyu Taek
Park, Joo Kyung
Lee, Jong Kyun
JOURNAL OF PERSONALIZED MEDICINE, 2022, 12 (06):
[39] Detection of Cholangiocarcinoma in Patients With Primary Sclerosing Cholangitis Using Single-Operator Cholangioscopy: A Prospective Evaluation and Cost Analysis
Forbes, Nauzer
Mohamed, Rachid
Heitman, Steven
Eksteen, Bertus
GASTROINTESTINAL ENDOSCOPY, 2016, 83 (05) : AB598 - AB599
[40] Probe-based confocal laser endomicroscopy in the evaluation of dominant strictures in patients with primary sclerosing cholangitis: results of a US multicenter prospective trial
Han, Samuel
Kahaleh, Michel
Sharaiha, Reem Z.
Tarnasky, Paul R.
Kedia, Prashant
Slivka, Adam
Chennat, Jennifer S.
Joshi, Virendra
Sejpal, Divyesh V.
Sethi, Amrita
Shah, Raj J.
GASTROINTESTINAL ENDOSCOPY, 2021, 94 (03) : 569 - +

← 1 2 3 4 5 →